University of Florida

Kate Therapeutics , which focuses on rare skeletal and cardiac muscle diseases and gene therapies employing novel capsid delivery to enable lower therapeutic doses, exited stealth on 8 June by simulta

Biopharmaceutical companies developing therapies for neurological diseases are in the midst of a boom, not only in terms of novel approaches to treating intractable diseases but also in terms of attra

City of Hope Licenses CTLX-CAR-T Candidate To Chimeric Independent research and treatment center City of Hope National Medical Center said on 21 September that it has licensed intellectual property

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie Opts Not To Continue Leber Conge